Effects of endothelin receptor antagonist TAK-044 on small bowel autograft from a controlled non-heart-beating donor model

Surgery

Volumn 130, Issue 5, 2001, Pages 819-825

  Sunose, Yutaka ^a,b   Ohwada, Susumu ^a,b   Takeyoshi, Izumi ^a,b   Matsumoto, Koshi ^a,b   Tsutsumi, Hirofumi ^a,b   Tomizawa, Naoki ^a,b   Kawate, Susumu ^a,b   Morishita, Yasuo ^a,b  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; TAK 044;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; GRAFT REJECTION; HEART BEAT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE TRANSPLANTATION; ISCHEMIA; NONHUMAN; PH; PRIORITY JOURNAL; REPERFUSION; SMALL INTESTINE; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN; TISSUE BLOOD FLOW; TISSUE INJURY;

EID: 0034751925     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.116928     Document Type: Article

References (27)

1. Successful small-bowel/liver transplantation
2. Current status of intestinal transplantation in children
3. Clinical intestinal transplantation: New perspectives and immunologic considerafions
4. Evaluation of preservation conditions and various solutions for small bowel preservation
5. Transplantation of kidneys harvested from non-heart-beating donors: Early and long-term results
6. Experience with liver and kidney allografts from non-heart-beating donors
7. Contribution of endothelin-1 to microcirculatory impairment in total hepatic ischemia and reperfusion injury
8. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
9. Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat
10. Blocked ETA receptors prevent ischemia and reperfusion injury in rat lungs
11. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver
12. Endothelin-A receptor antagonism improves small bowel graft perfusion and structure after ischemia and reperfusion
13. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors
14. Intramucosal pH and intestinal mucosal damage in ischemia-reperfusion injurry
15. Effects of FR167653 on small bowel ischemia-reperfusion injury in dogs
16. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion
17. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
18. Oxygen-derived free radicals in postischemic tissue injury
19. Roles of ET-1 in endotoxin-induced microcirculatory disturbance in rat small intestine
20. Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine
21. Systemic endothelin blockade decreases peripheral vascular resistance and blood pressure in humans
22. Modulation of endothelin and nitric oxide: A rational approach to improve canine hepatic microcirculation
23. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044
24. Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats
25. Early mucosal and microvascular changes in feline intestinal transplants
26. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma
27. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure